Mengler Christopher 4
4 · IMPAX LABORATORIES INC · Filed Mar 9, 2010
Insider Transaction Report
Form 4
Mengler Christopher
President, Global Pharm. Div.
Transactions
- Tax Payment
Common Stock
2010-03-05$16.48/sh−2,294$37,805→ 44,706 total
Footnotes (1)
- [F1]These shares of common stock were surrendered upon vesting of a restricted stock award to satisfy the Reporting Person's payroll tax withholding obligations. Such surrender is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.